New Zealand markets close in 3 hours 30 minutes

Bio-Techne Corporation (TECH)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
81.95+1.28 (+1.59%)
At close: 04:00PM EST
82.60 +0.65 (+0.79%)
After hours: 06:55PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 13.29B
Enterprise value 13.43B
Trailing P/E 47.38
Forward P/E 62.50
PEG ratio (5-yr expected) N/A
Price/sales (ttm)12.39
Price/book (mrq)7.59
Enterprise value/revenue 12.02
Enterprise value/EBITDA 29.69

Trading information

Stock price history

Beta (5Y monthly) 1.27
52-week change 3-31.37%
S&P500 52-week change 3-15.72%
52-week high 3130.74
52-week low 368.00
50-day moving average 377.82
200-day moving average 389.33

Share statistics

Avg vol (3-month) 31.26M
Avg vol (10-day) 3816.55k
Shares outstanding 5156.97M
Implied shares outstanding 6N/A
Float 8155.67M
% held by insiders 10.79%
% held by institutions 197.91%
Shares short (14 Nov 2022) 43.04M
Short ratio (14 Nov 2022) 42
Short % of float (14 Nov 2022) 42.51%
Short % of shares outstanding (14 Nov 2022) 41.94%
Shares short (prior month 13 Oct 2022) 42.71M

Dividends & splits

Forward annual dividend rate 40.32
Forward annual dividend yield 40.40%
Trailing annual dividend rate 30.32
Trailing annual dividend yield 30.40%
5-year average dividend yield 40.54
Payout ratio 417.90%
Dividend date 327 Nov 2022
Ex-dividend date 409 Nov 2022
Last split factor 24:1
Last split date 329 Nov 2022

Financial highlights

Fiscal year

Fiscal year ends 29 Jun 2022
Most-recent quarter (mrq)29 Sept 2022

Profitability

Profit margin 26.13%
Operating margin (ttm)26.50%

Management effectiveness

Return on assets (ttm)8.01%
Return on equity (ttm)16.71%

Income statement

Revenue (ttm)1.12B
Revenue per share (ttm)7.12
Quarterly revenue growth (yoy)4.60%
Gross profit (ttm)758.09M
EBITDA 358.48M
Net income avi to common (ttm)291.88M
Diluted EPS (ttm)1.79
Quarterly earnings growth (yoy)28.60%

Balance sheet

Total cash (mrq)203.08M
Total cash per share (mrq)1.29
Total debt (mrq)341.53M
Total debt/equity (mrq)19.50
Current ratio (mrq)4.01
Book value per share (mrq)11.16

Cash flow statement

Operating cash flow (ttm)332.92M
Levered free cash flow (ttm)257.5M